Osteosarcoma: a review of diagnosis, management, and treatment strategies, Clin Adv Hematol Oncol, vol.8, pp.705-718, 2010. ,
Biology and therapeutic advances for pediatric osteosarcoma, Oncologist, vol.9, pp.422-441, 2004. ,
The epidemiology of osteosarcoma, Cancer Treat Res, vol.152, pp.3-13, 2009. ,
Current concepts on the molecular biology of osteosarcoma, Cancer Treat Res, vol.152, pp.467-478, 2009. ,
MicroRNA Involvement in Osteosarcoma, Sarcoma, p.359739, 2012. ,
Epigenetic upregulation of HGF and c-Met drives metastasis in hepatocellular carcinoma, PLoS One, vol.8, p.63765, 2013. ,
Inhibition of c-Met and prevention of spontaneous metastatic spreading by the 2-indolinone RPI ,
, Mol Cancer Ther, vol.5, pp.2388-2397, 2006.
Norstictic Acid Inhibits Breast Cancer Cell Proliferation, Migration, Invasion, and In Vivo Invasive Growth Through Targeting C-Met, Phytother Res, vol.30, pp.557-566, 2016. ,
DOI : 10.1002/ptr.5551
URL : http://europepmc.org/articles/pmc5045260?pdf=render
c-MET expression in colorectal adenomas and primary carcinomas with its corresponding metastases, J Gastrointest Oncol, vol.6, pp.618-627, 2015. ,
Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling, Cancer Res, vol.67, pp.7675-7685, 2007. ,
DOI : 10.1158/0008-5472.can-06-4697
URL : http://cancerres.aacrjournals.org/content/67/16/7675.full.pdf
Clinical applications for microRNAs in cancer, Clin Pharmacol Ther, vol.93, pp.98-104, 2013. ,
MicroRNAs as potential biomarkers in human solid tumors, Cancer Lett, vol.329, pp.125-136, 2013. ,
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14, Cell, vol.75, pp.843-854, 1993. ,
URL : https://hal.archives-ouvertes.fr/in2p3-00597159
Control of developmental timing by micrornas and their targets, Annu Rev Cell Dev Biol, vol.18, pp.495-513, 2002. ,
, MicroRNAs in cancer: small molecules with a huge impact, J Clin Oncol, vol.15, pp.5848-5856, 2009.
Oncomirs-microRNAs with a role in cancer, Nat Rev Cancer, vol.6, pp.259-269, 2006. ,
miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells, Int J Mol Med, vol.30, pp.1013-1020, 2012. ,
microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2, Oncol Rep, vol.24, pp.1363-1369, 2010. ,
Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients, Oncol Rep, vol.31, pp.1263-1270, 2014. ,
miR-454 is down-regulated in osteosarcomas and suppresses cell proliferation and invasion by directly targeting c-Met, Cell Prolif, vol.48, pp.348-355, 2015. ,
Targeting microRNAs in cancer: rationale, strategies and challenges, Nat Rev Drug Discov, vol.9, pp.775-789, 2010. ,
MicroRNAs direct rapid deadenylation of mRNA, Proc Natl Acad Sci, vol.103, pp.4034-4039, 2006. ,
miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo, Cancer Biol Ther, vol.10, pp.190-197, 2010. ,
miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway, FEBS Lett, vol.585, pp.2229-2234, 2011. ,
MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development, J Biol Chem, vol.284, pp.29596-29604, 2009. ,
DOI : 10.1074/jbc.m109.020511
URL : http://www.jbc.org/content/284/43/29596.full.pdf
The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited, Nat Rev Cancer, vol.3, pp.453-458, 2003. ,
Understanding the Biology of Bone Sarcoma from Early Initiating Events through Late Events in Metastasis and Disease Progression, Front Oncol, vol.3, p.230, 2013. ,
MicroRNA-26b inhibits metastasis of osteosarcoma via targeting CTGF and Smad1, Tumour Biol, vol.36, pp.6201-6209, 2015. ,
MicroRNA33b suppresses migration and invasion by targeting c-Myc in osteosarcoma cells, PLoS One, vol.9, p.115300, 2014. ,
Crizotinib, a c-Met inhibitor, prevents metastasis in a metastatic uveal melanoma model, Mol Cancer Ther, vol.12, pp.2817-2826, 2013. ,
Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway, Oncogene, vol.21, pp.2309-2319, 2002. ,
Src and FAK mediate cell-matrix adhesion-dependent activation of Met during transformation of breast epithelial cells, J Cell Biochem, vol.107, pp.1168-1181, 2009. ,
Epigallocatechin-3-gallate inhibits osteosarcoma cell invasiveness by inhibiting the MEK/ERK signaling pathway in human osteosarcoma cells, J Environ Pathol Toxicol Oncol, vol.34, pp.85-93, 2015. ,
Cyr61 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by Raf-1/MEK/ERK/Elk-1/TWIST-1 signaling pathway, Mol Cancer, vol.13, p.236, 2014. ,
Knockdown of Aurora-B inhibits osteosarcoma cell invasion and migration via modulating PI3K/Akt/NF-kappaB signaling pathway, Int J Clin Exp Pathol, vol.7, pp.3984-3991, 2014. ,
Reduction of metastasis, cell invasion, and adhesion in mouse osteosarcoma by YM529/ONO-5920induced blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathway, Toxicol Appl Pharmacol, vol.259, pp.402-410, 2012. ,
MicroRNA-198 inhibited tumorous behaviors of human osteosarcoma through directly targeting ROCK1, Biochem Biophys Res Commun, vol.472, pp.557-565, 2016. ,
Decreased miR-198 expression and its prognostic significance in human gastric cancer, World J Surg Oncol, vol.14, p.33, 2016. ,
miR-198 targets SHMT1 to inhibit cell proliferation and enhance cell apoptosis in lung adenocarcinoma, Tumour Biol, vol.37, pp.5193-202, 2016. ,
MiR-198 represses tumor growth and metastasis in colorectal cancer by targeting fucosyl transferase 8, Sci Rep, vol.4, p.6145, 2014. ,
Serum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcoma, Int J Clin Exp Pathol, vol.7, pp.4194-4203, 2014. ,
Roles of microRNA-206 in osteosarcoma pathogenesis and progression, Asian Pac J Cancer Prev, vol.14, pp.3751-3755, 2013. ,
Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models, Cancer Gene Ther, vol.17, pp.387-397, 2010. ,
Profiling of chemonaive osteosarcoma and paired-normal cells identifies EBF2 as a mediator of osteoprotegerin inhibition to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis, Clin Cancer Res, vol.15, pp.5082-5091, 2009. ,
miR137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes, J Invest Dermatol, vol.133, pp.768-775, 2013. ,